Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 148.1B | 170.5B | 175.5B | 134.7B |
Cost of revenue | 128.1B | 115.7B | 140.8B | 115.2B |
Gross profit | 20.0B | 54.8B | 34.7B | 19.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.3B | 23.0B | 3.7B | 3.3B |
Other operating expenses | 9.6B | -13.2B | 10.6B | 9.3B |
Operating income | 16.5B | 13.6B | 15.0B | 10.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.7B | 2.5B | 2.3B | 2.4B |
Other income expense | — | — | — | — |
Pretax income | 14.8B | 12.2B | 14.0B | 9.5B |
Tax provision | 3.9B | 3.5B | 3.5B | 2.4B |
Net income | 10.9B | 8.7B | 10.5B | 7.0B |
Basic EPS | 12.3 | — | 11.8 | 7.9 |
Diluted EPS | 12.3 | — | 11.8 | 7.9 |
Basic average shares | 887.0M | — | 887.3M | 886.6M |
Diluted average shares | 887.0M | — | 887.3M | 887.8M |
EBITDA | 19.4B | 16.5B | 18.0B | 13.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |